Clovis Oncology Inc (CLVS) is near the top in its industry group according to InvestorsObserver. CLVS gets an overall rating of 50. That means it scores higher than 50 percent of stocks. Clovis Oncology Inc gets a 67 rank in the Biotechnology industry. Biotechnology is number 99 out of 148 industries.

Click Here to get the full Stock Score Report on Clovis Oncology Inc (CLVS) Stock.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 50 means the stock is more attractive than 50 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Clovis Oncology Inc (CLVS) stock is trading at $5.51 as of 1:00 PM on Tuesday, Nov 12, an increase of $0.13, or 2.32% from the previous closing price of $5.38. The stock has traded between $5.25 and $5.91 so far today. Volume today is 4,592,272 compared to average volume of 5,433,499.

To screen for more stocks like CLVS click here.

Here is the original post:
Where Does CLVS Stock Rank in the Biotechnology Industry? - InvestorsObserver